美国的造血细胞移植途径。
Access to hematopoietic cell transplantation in the United States.
机构信息
Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota, USA.
出版信息
Biol Blood Marrow Transplant. 2010 Aug;16(8):1070-5. doi: 10.1016/j.bbmt.2009.12.529. Epub 2009 Dec 28.
Abstract
Hematopoietic cell transplantation (HCT) is a highly specialized and resource-intense medical procedure that can be associated with disparities in access to transplantation. Barriers to access to HCT are multifactorial, complex, and interrelated. Our current knowledge of specific barriers that prevent access to HCT is very limited. As the utilization of HCT increases, it is imperative that underserved populations receive the benefit of this life-saving procedure. We review the prevailing literature on access to HCT and describe research priorities for eliminating disparities in transplantation. Better understanding of these complex barriers will minimize inequities, inform health policy, guide development of interventions targeted to eliminate disparities, and continue the expansion of HCT in the future.
摘要
造血细胞移植（HCT）是一项高度专业化且资源密集型的医疗程序，可能存在移植机会方面的差异。获得 HCT 的障碍是多因素的、复杂的且相互关联的。我们目前对阻止获得 HCT 的具体障碍的了解非常有限。随着 HCT 的应用增加，必须确保服务不足的人群能够从这种救命手术中受益。我们回顾了关于获得 HCT 的现有文献，并描述了消除移植差异的研究重点。更好地了解这些复杂的障碍将最大限度地减少不平等，为卫生政策提供信息，指导旨在消除差异的干预措施的制定，并在未来继续扩大 HCT 的应用。
相似文献
1
Access to hematopoietic cell transplantation in the United States.美国的造血细胞移植途径。
Biol Blood Marrow Transplant. 2010 Aug;16(8):1070-5. doi: 10.1016/j.bbmt.2009.12.529. Epub 2009 Dec 28.
2
Racial disparities in hematopoietic cell transplantation in the United States.美国造血细胞移植中的种族差异。
Bone Marrow Transplant. 2012 Nov;47(11):1385-90. doi: 10.1038/bmt.2011.214. Epub 2011 Nov 7.
3
Increasing access to allotransplants in the United States: the impact of race, geography, and socioeconomics.增加美国异体移植的可及性：种族、地理位置和社会经济的影响。
Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):275-280. doi: 10.1182/hematology.2021000259.
4
Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.美国成人造血细胞移植的障碍：一项以年龄为重点的系统评价
Biol Blood Marrow Transplant. 2020 Dec;26(12):2335-2345. doi: 10.1016/j.bbmt.2020.09.013. Epub 2020 Sep 20.
5
Geographic access to hematopoietic cell transplantation services in the United States.美国造血细胞移植服务的地理可及性。
Bone Marrow Transplant. 2016 Feb;51(2):241-8. doi: 10.1038/bmt.2015.246. Epub 2015 Oct 12.
6
Barriers to accessing health care for hematopoietic cell transplantation recipients living in rural areas: perspectives from healthcare providers.农村地区造血干细胞移植受者获得医疗保健的障碍：医疗服务提供者的观点
Clin J Oncol Nurs. 2013 Aug 1;17(4):405-11. doi: 10.1188/13.CJON.405-411.
7
Barriers to hematopoietic cell transplantation clinical trial participation of african american and black youth with sickle cell disease and their parents.镰状细胞病非裔美国和黑人青年及其父母参与造血细胞移植临床试验的障碍。
J Pediatr Hematol Oncol. 2013 May;35(4):289-98. doi: 10.1097/MPH.0b013e31828d5e6a.
8
Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients.医疗保险患者异基因造血细胞移植后获得和负担救命药物的挑战。
Biol Blood Marrow Transplant. 2017 Aug;23(8):1387-1392. doi: 10.1016/j.bbmt.2017.04.010. Epub 2017 Apr 12.
9
Disparities in access to hematopoietic cell transplant persist at a transplant center.在移植中心，造血细胞移植的机会仍然存在差异。
Bone Marrow Transplant. 2024 Sep;59(9):1258-1264. doi: 10.1038/s41409-024-02327-x. Epub 2024 Jun 13.
10
Access to hematopoietic stem cell transplantation: effect of race and sex.造血干细胞移植的途径：种族和性别的影响。
Cancer. 2010 Jul 15;116(14):3469-76. doi: 10.1002/cncr.25297.
引用本文的文献
1
Access to Transplant Care and Social Determinants of Health.获得移植护理与健康的社会决定因素
Adv Exp Med Biol. 2025;1475:1-8. doi: 10.1007/978-3-031-84988-6_1.
2
Development of an eHealth Mindfulness-Based Music Therapy Intervention for Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: Qualitative Study.为接受异基因造血干细胞移植的成年人开发基于正念的电子健康音乐治疗干预措施：定性研究
JMIR Form Res. 2025 Apr 11;9:e65188. doi: 10.2196/65188.
3
Allogeneic Stem Cell Transplant in Hematological Disorders: A Decade of Experience.血液系统疾病中的异基因干细胞移植：十年经验
Int J Hematol Oncol Stem Cell Res. 2024 Oct 1;18(4):344-357. doi: 10.18502/ijhoscr.v18i4.16759.
4
Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants.血液与骨髓移植临床试验网络（BMT CTN）试验参与者的代表性。
Transplant Cell Ther. 2025 Jan;31(1):49-57. doi: 10.1016/j.jtct.2024.10.014. Epub 2024 Nov 1.
5
Can you spare 100 days? The allogeneic hematopoietic cell transplant caregiver requirement from the perspective of social workers.你能抽出 100 天时间吗？从社会工作者的角度看异基因造血细胞移植患者照料者的需求。
Support Care Cancer. 2024 Oct 12;32(11):723. doi: 10.1007/s00520-024-08906-4.
6
Disparities in access to hematopoietic cell transplant persist at a transplant center.在移植中心，造血细胞移植的机会仍然存在差异。
Bone Marrow Transplant. 2024 Sep;59(9):1258-1264. doi: 10.1038/s41409-024-02327-x. Epub 2024 Jun 13.
7
Haploidentical and Matched Sibling Transplantation for Acute Myeloid Leukemia: A Hospital-Based Study.单倍体相合及全相合同胞移植治疗急性髓系白血病：一项基于医院的研究
J Hematol. 2023 Dec;12(6):255-267. doi: 10.14740/jh1162. Epub 2023 Dec 28.
8
Dental evaluation and clearance prior to allogeneic hematopoietic cell transplantation.异基因造血细胞移植前的口腔评估和清除。
Oral Dis. 2024 May;30(4):2635-2644. doi: 10.1111/odi.14717. Epub 2023 Aug 31.
9
Racial and Socioeconomic Disparities in Long-Term Outcomes in ≥1 Year Allogeneic Hematopoietic Cell Transplantation Survivors: A CIBMTR Analysis.≥1 年异基因造血细胞移植幸存者的长期结局中的种族和社会经济差异：CIBMTR 分析。
Transplant Cell Ther. 2023 Nov;29(11):709.e1-709.e11. doi: 10.1016/j.jtct.2023.07.013. Epub 2023 Jul 22.
10
Lack of disease control remains a major barrier to transplant for older patients with AML.缺乏疾病控制仍然是老年急性髓系白血病患者移植的主要障碍。
Bone Marrow Transplant. 2023 Sep;58(9):1054-1056. doi: 10.1038/s41409-023-02022-3. Epub 2023 Jun 23.
本文引用的文献
1
Costs of hematopoietic cell transplantation: comparison of umbilical cord blood and matched related donor transplantation and the impact of posttransplant complications.造血细胞移植的成本：脐带血与匹配的相关供体移植的比较以及移植后并发症的影响。
Biol Blood Marrow Transplant. 2009 May;15(5):564-73. doi: 10.1016/j.bbmt.2009.01.011. Epub 2009 Mar 9.
2
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.社会经济地位对癌症发病率及诊断时分期的影响：来自监测、流行病学及最终结果：国家纵向死亡率研究的选定发现
Cancer Causes Control. 2009 May;20(4):417-35. doi: 10.1007/s10552-008-9256-0. Epub 2008 Nov 12.
3
Race, gender, and socioeconomic disparities in CKD in the United States.美国慢性肾脏病中的种族、性别和社会经济差异。
J Am Soc Nephrol. 2008 Jul;19(7):1261-70. doi: 10.1681/ASN.2008030276. Epub 2008 Jun 4.
4
Costs of allogeneic hematopoietic cell transplantation with high-dose regimens.高剂量方案的异基因造血细胞移植成本。
Biol Blood Marrow Transplant. 2008 Feb;14(2):197-207. doi: 10.1016/j.bbmt.2007.10.010.
5
Association of insurance with cancer care utilization and outcomes.保险与癌症医疗利用及结局的关联。
CA Cancer J Clin. 2008 Jan-Feb;58(1):9-31. doi: 10.3322/CA.2007.0011. Epub 2007 Dec 20.
6
Cancer mortality in the United States by education level and race.美国按教育水平和种族划分的癌症死亡率。
J Natl Cancer Inst. 2007 Sep 19;99(18):1384-94. doi: 10.1093/jnci/djm127. Epub 2007 Sep 11.
7
Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests.患者的焦虑与期望：它们如何影响家庭医生开具癌症筛查检查的决定。
Can Fam Physician. 2005 Dec;51(12):1658-9.
8
The cardiovascular state of the union: confronting healthcare disparities.美国的心血管状况：应对医疗保健差距。
Circulation. 2005 Mar 15;111(10):1205-7. doi: 10.1161/01.CIR.0000160705.97642.92.
9
Hematopoietic stem cell transplantation among patients with leukemia of all ages in Texas.德克萨斯州各年龄段白血病患者的造血干细胞移植情况。
Cancer. 2004 Nov 15;101(10):2230-8. doi: 10.1002/cncr.20628.
10
Racial and ethnic disparities in health care: a position paper of the American College of Physicians.医疗保健中的种族和族裔差异：美国医师学会立场文件
Ann Intern Med. 2004 Aug 3;141(3):226-32. doi: 10.7326/0003-4819-141-3-200408030-00015.
Zotero 插件